Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreat...

Basic Information

ID: ALA3744252

Type: Binding

Description: Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay

Format: BAO_0000221

Organism: Homo sapiens

Tissue: Blood

Target:  Prostanoid EP4 receptor(ALA1836)

Document:  ALA3739413

Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
491.624.144.14
352.445.775.77
396.455.475.47
396.455.475.47
426.474.964.96
426.474.964.96
395.466.076.07
395.466.076.07
425.485.575.57
425.485.575.57
429.906.736.73